Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Deborah Rudin

4PUBLICATIONS
4CO-AUTHORS
Pacific Peoples theory of change models for healthPreventative health careInnate immunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Feb 20, 2025
US consumer and healthcare professional preferences for combination COVID-19 and influenza vaccines.

Christine Poulos, Philip O Buck, Parinaz Ghaswalla

|Dec 31, 2024
The Impact of Vaccination on COVID-19, Influenza, and Respiratory Syncytial Virus-Related Outcomes: A Narrative Review.

Roberto Debbag, Deborah Rudin, Francesca Ceddia

|Nov 18, 2024
Seasonal influenza vaccines: Variability of immune responses to B lineage viruses.

Matthew S Miller, Emanuele Montomoli, Eyal Leshem

|Apr 15, 2024
Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines.

Colin A Russell, Ron A M Fouchier, Parinaz Ghaswalla

Pageof 1

Frequent Collaborators

1 joint publications

Christine Poulos

1 joint publications

Philip O Buck

1 joint publications

Parinaz Ghaswalla

1 joint publications

Darshan Mehta

Frequent Collaborators

1 joint publications

Christine Poulos

1 joint publications

Philip O Buck

1 joint publications

Parinaz Ghaswalla

1 joint publications

Darshan Mehta

Top Related Videos

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

35.8K
An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

7.9K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on : Jul 26, 2019

8.1K
See more related videos

Top Related Videos

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition (HI) Assay to Quantify Influenza-specific Antibody Titers

Published on : Dec 01, 2017

35.8K
An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An <em>In vitro</em> Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on : Dec 10, 2013

7.9K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on : Jul 26, 2019

8.1K
See more related videos